Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment
Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment
复制标题
空间分布的淀粉样蛋白-β降低轻度认知障碍患者的糖代谢
DOI:
10.3233/jad-190560
复制
发表时间:
2020-01-01
影响因子:
4
通讯作者:
Bedell, Barry J.
中科院分区:
文献类型:
--
作者:
Carbonell, Felix;Zijdenbos, Alex P.;Bedell, Barry J.
Background: Several positron emission tomography (PET) studies have explored the relationship between amyloid-beta (A beta), glucose metabolism, and the APOE epsilon 4 genotype. It has been reported that APOE epsilon 4, and not aggregated A beta, contributes to glucose hypometabolism in pre-clinical stages of Alzheimer's disease (AD) pathology.Objective: We hypothesize that typical measurements of A beta taken either from composite regions-of-interest with relatively high burden actually cover significant patterns of the relationship with glucose metabolism. In contrast, spatially weighted measures of A beta are more related to glucose metabolism in cognitively normal (CN) aging and mild cognitive impairment (MCI).Methods: We have generated a score of amyloid burden based on a joint singular value decomposition (SVD) of the cross-correlation structure between glucose metabolism, as measured by [F-18]2-fluoro-2-deoxyglucose (FDG) PET, and A beta, as measured by [F-18] florbetapir PET, from the Alzheimer's Disease Neuroimaging Initiative study. This SVD-based score reveals cortical regions where a reduced glucose metabolism is maximally correlated with distributed patterns of A beta.Results: From an older population of CN and MCI subjects, we found that the SVD-based A beta score was significantly correlated with glucose metabolism in several cortical regions. Additionally, the corresponding A beta network has hubs that contribute to distributed glucose hypometabolism, which, in turn, are not necessarily foci of A beta deposition.Conclusions: Our approach uncovered hidden patterns of the glucose metabolism-A beta relationship. We showed that the SVD-based A beta score produces a stronger relationship with decreasing glucose metabolism than either APOE epsilon 4 genotype or global measures of A beta burden.